TB

Tulasi Ballav Swain

Active Director Director DIN 07423649
DIN 07423649 First appointment Feb 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2016
Shareholding value •••• Premium profile

About Tulasi Ballav Swain

Data last updated:

Tulasi Ballav Swain is a Director at Phc Life Sciences Private Limited (since 2016). The company operates in Pharma. Phc Life Sciences Private Limited reported revenue of ₹9.5 Lakh (FY 2024).

DIN 07423649
Primary Designation Director
Industry Pharma
First Appointment 18 Feb 2016
Oldest Company Age 10 yrs
Largest company Phc Life Sciences Private Limited · ₹9.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Phc Life Sciences Private Limited U51397OR2016PTC019931
Director18 Feb 20162016₹9.5 Lakh (FY 2024)Active

Board colleagues of Tulasi Ballav Swain

NameDINCompanyDesignation
Namitarani Pradhan07423664Phc Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Phc Life Sciences Private Limited
Premium access

Shareholding and investment profile for Tulasi Ballav Swain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tulasi Ballav Swain

Tulasi Ballav Swain currently holds 1 directorship: Phc Life Sciences Private Limited (Director, since 18 Feb 2016, revenue ₹9.5 Lakh (FY 2024)).

Tulasi Ballav Swain was first appointed on 18 Feb 2016 as Director at Phc Life Sciences Private Limited.

The current boards of Tulasi Ballav Swain's companies include Namitarani Pradhan (Phc Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available